Use of trezastilbenoside in manufacture of product for treating and/or preventing disease of respiratory system
US11744841B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Dec 29, 2020 |
| Grant date | Sep 5, 2023 |
| Priority date | — |
| Expiry date | Jan 2, 2041 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P11/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure belongs to the biopharmaceutical field, and discloses uses of Trezastilbenoside in manufacture of a product for treating and/or preventing a disease of respiratory system, and particularly uses of Trezastilbenoside in manufacture of a product for treating and/or preventing a disease of respiratory system with symptoms of cough and/or expectoration and/or asthma. As indicated by the test results of the present disclosure, Trezastilbenoside has significant efficacy of relieving cough, eliminating phlegm, relieving asthma and anti-inflammation, and has a potential therapeutic effect on respiratory system diseases, thus possessing broad prospects in clinical application.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.